
Prime Stock alert: Moving this tonnage stock to a HOLD
We are moving an industrial sector stock that we recommended in June 2022, to a HOLD.

We are moving an industrial sector stock that we recommended in June 2022, to a HOLD.

We are moving this Prime Stock to a HOLD and this report will explain why.

We think the time is right to partially sell your holdings of this API maker and hold the rest.

In part one of this four-part series we talk about examples of wrong entry into stocks with rich valuations and how to avoid them

The second of this four-part series will talk about how you can lose wealth when you entry timing goes wrong in cyclical businesses.

The third of this four-part series talks about how every bull market hides low quality businesses and how you can stay clear of such companies.

In this final part of this four-part series we discuss how many promising turnaround stories never say the light of day in the stock market and also talk about the perils of placing too much faith in dividend earners that show no potential for growth.

The Nifty 50 has scaled new highs, displaying strength over the past few months. Is the rally in the Nifty 50 over or can it continue?

For shareholders of HDFC, should you continue holding the stock post its merger with HDFC Bank?

When a company, especially an MNC, discloses little by way of scheduled earnings calls or business information, save for its AGM, its stock price can also react only to earnings or move on visibility in prospects of the company. We took that risk in one such company which is in the business of automation, in late 2021.

With consumer companies having pulled through a period of demand slump, the worst appears to be behind. Signs of a recovery in rural demand can help broad-base the overall consumption improvement. This consumer company gets a strong foundation in its household brand names. But it has been evolving from building up its own health and […]

The demerger of Piramal Enterprises (PEL) was a long awaited one in the market. With sizable businesses in both financial services and pharmaceuticals, the demerger
Hold On
You are being redirected to another page,